Study S003336

A Randomized, Open-label, Parallel, Treat to Target Study Comparing the Efficacy and Safety of HR17031 With Insulin Glargine in Chines Subjects With Type 2 Diabetes Inadequately Controlled With Metformin in Combination With or Without Another Oral Antidiabetic Drug (OAD)

ClinicalTrials.gov record

Registration

Registration: NCT06881264
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: NONE
Status: COMPLETED
Enrollment: 401
Start: 2024-04-30
Primary completion: 2025-09-19
Lead sponsor: Jiangsu HengRui Medicine Co., Ltd.
Conditions: Adult Patients With Type 2 Diabetes Uncontrolled on Oral Antidiabetic Drugs
Interventions: DRUG:HR17031 injection; DRUG:insulin glargine
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

Change in HbA1c: Changes in HbA1c from baseline to week 26 [week 26]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.